Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.32
    +1.42 (+1.73%)
     
  • GOLD FUTURES

    2,340.20
    -6.20 (-0.26%)
     
  • DOW

    38,518.76
    +278.78 (+0.73%)
     
  • Bitcoin GBP

    53,549.05
    +222.86 (+0.42%)
     
  • CMC Crypto 200

    1,437.43
    +22.67 (+1.60%)
     
  • NASDAQ Composite

    15,722.76
    +271.45 (+1.76%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Global Retinal Surgery Device Market (2021 to 2027) - Featuring Topcon, Alcon and Carl Zeiss Among Others

Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Retinal Surgery Device Market, Global Forecast, Impact of COVID-19, Industry Trends, by Product, Growth, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Retinal diseases vary widely, but most retinal diseases cause visual symptoms and can affect any part of the retina. The various equipment and accessories used for surgically repairing torn or detached retinas are retinal surgery devices. Worldwide, devices are usually manufactured using stainless steel and medical-grade silicon for better sterility. The common symptoms of retinal diseases are blurred or distorted vision, defects inside vision or lost vision. Globally, Retinal surgeries devices are used to repair retinal torn or detached retinas through laser surgery, cryotherapy. Apart from this, the devices are also used in diabetic retinopathy and other ophthalmic procedures. According to the publisher, the Global Retinal Surgery Device Market is projected to reach US$ 2.70 Billion by 2027.

Factors Driving the Retinal Surgery Device Industry

Furthermore, globally surging geriatric population, age-related eye disorders, say glaucoma, cataract which can cause loss of vision, is also giving traction to the market growth. More on this, macular degeneration, diabetic retinopathy currently represents the driving force towards this market. Also, worldwide, there is widespread adoption of minimally invasive surgical procedures for the treatment of such diseases, which offer various benefits like minimal pain and discomfort and quick recovery. As per this research report, Worldwide Retinal Surgery Device Market Size was valued at US$ 1.59 Billion in 2020.

Some Facts

  • As per WHO, by 2050, the world population aged 60 years and older is likely to be 2 billion.

  • The National Diabetes Statistics stated, one often is suffering from diabetes, around 9.4% of the total United States population.

  • Diabetic retinopathy impacts nearly 7.7 million Americans and the number likely to surge to 11.3 million by 2030.

COVID-19 Impact

The COVID-19 pandemic has spread worldwide; millions of people around the globe are infected with COVID-19 disease. Restriction and lockdowns have impacted retinal surgery as most of the medical strength have been assigned to fight the pandemic. But the publisher believes the scenario to improve in future.

The publisher has covered the Global Retinal Surgery Device market into Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment and Others. Vitrectomy Pack is one of the key segments in by product category due to its adoption in the application such as combined retinal surgical procedures, vitreous removal in the mobile retina, epiretinal membrane removal, in posterior vitreous detachment procedures. As per the research analysis, Global Retinal Surgery Device Industry is likely to grow at a CAGR of 7.86% from 2020-2027.

The publisher has studied the Global Retinal Surgery Device market into Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others. Diabetic Retinopathy dominates the market during the forecast period as it can develop in people suffering from type 1 or type 2 diabetes. Approximately 463 million adults aged 20-79 years were living with diabetes, according to International Diabetes Federation (IDF). And by 2045, these figures would surge to 700 million adults. Also, 79% of adults who have diabetes were from developing nations.

The report covers the region, North America, Latin America, Europe, Asia Pacific, Middle East & Africa in this report. The North American region holds the dominating position in the global retinal surgery device market. The key players playing a crucial role in the retinal surgery market globally are Topcon Corporation, Alcon AG, Carl Zeiss, Bausch Health Companies Inc and Iridex Corporation.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Retinal Surgery Devices Market

6. Market Share
6.1 By Product
6.2 By Application
6.3 By End User
6.4 By Region

7. Product - Retinal Surgery Devices Market
7.1 Vitrectomy Machines
7.2 Vitrectomy Packs
7.3 Surgical Instruments
7.4 Microscopic Illumination Equipment
7.5 Retinal Laser Equipment
7.6 Others

8. Application - Retinal Surgery Devices Market
8.1 Diabetic Retinopathy
8.2 Retinal Detachment
8.3 Epiretinal Membrane
8.4 Macular Hole
8.5 Others

9. End User - Retinal Surgery Devices Market
9.1 Hospitals
9.2 Eye Clinics
9.3 Others

10. Region - Retinal Surgery Devices Market
10.1 North America
10.2 Latin America
10.3 Europe
10.4 Asia Pacific
10.5 Middle East & Africa

11. Company Analysis
11.1 Topcon Corporation
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Financial Insights
11.2 Alcon AG
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Financial Insights
11.3 Carl Zeiss
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Financial Insights
11.4 Bausch Health Companies Inc
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Financial Insights
11.5 Iridex Corporation
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Financial Insights

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/drckuf

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900